Announcement PDF 20 March 2026 ASX RELEASE UPDATE RE MANAGEMENT DIVESTMENT OF SHARES Electro Optic Systems Holdings Limited (“EOS” or the “Company”) (ASX:EOS), today announces that the EOS CEO & Managing Director (Dr Andreas Schwer) and the CFO/COO (Mr Clive Cuthell) have undertaken a planned divestment of EOS Shares. This follows the announcement on 17 March 2026 that Dr Schwer, Mr Cuthell and certain other EOS managers had exercised options to buy shares in EOS and planned to divest some EOS shares. In addition, two Non-Executive Directors have bought and sold shares respectively, see details below. DIVESTMENT AND SHARES HELD – DR ANDREAS SCHWER As disclosed in a separate Appendix 3Y announcement today, Dr Schwer divested 1,500,000 EOS shares on 19 March 2026. Following this divestment, Dr Schwer holds 1,407,211 shares in EOS, valued at approximately $13.6m (based on yesterday’s closing price of $9.65). MINIMUM SHAREHOLDING POLICY On 30 December 2025, EOS published a Minimum Shareholding Policy. Among other things, this policy requires that the CEO & Managing Director (Dr Schwer) holds a minimum of 4 times his fixed annual remuneration in EOS shares. In addition, the CFO/COO (Mr Cuthell) is required to hold a minimum of 3 times his fixed annual remuneration in EOS shares. As of the date of this announcement, Dr Schwer and Mr Cuthell retain shareholdings significantly in excess of the minimum shareholding policy requirement. FUTURE PLANS Dr Schwer has advised the Board of Directors that he has no intention to make further divestments before the next trading window which may open in mid-April 2026. As normal, any future dealings in EOS shares will be subject to approval by the EOS Board of Directors in accordance with the EOS Securities Trading Policy INTERESTS IN UNVESTED LTI PLAN – DR ANDREAS SCHWER As disclosed in the relevant Appendix 3Y published today, in addition to the above shares held, under the EOS LTI Plan (Omnibus Employee Incentive Plan or OEIP) as at the date of this announcement Dr Schwer holds interests in a total of 585,929 unvested share rights and 986,842 unvested share options. These unvested entitlements will not vest with Dr Schwer unless the relevant vesting conditions are met. Full details of the vesting conditions and other aspects of the OEIP are included in the 2025 Financial Report published on 23 February 2026. The scheduled testing dates for vesting are December 2026, 2027 and 2028. TRADING BY NON-EXECUTIVE DIRECTOR – GARRY HOUNSELL On 18 March 2026, Mr Garry Hounsell, Chairman of the Board of Directors purchased 5,000 shares in EOS at a price of between $9.15-$9.17. Following this transaction, Mr Hounsell holds 522,647 shares valued at $5.0m (based on yesterday’s closing price of $9.65). More details are included in an Appendix 3Y announcement published today. TRADING BY NON-EXECUTIVE DIRECTOR –KATE LUNDY On 18 March 2026, Ms Kate Lundy, Non-Executive Director divested of 13,000 shares in EOS at a price of $8.96. Following this transaction, Ms Lundy holds 18,431 shares valued at $0.2m (based on yesterday’s closing price of $9.65). More details are included in an Appendix 3Y announcement published today. This document was authorised for release by David Black, Chair of Audit and Risk Committee and Non-Executive Director DAVID BLACK Chair of Audit and Risk Committee and Independent Non Executive Director ir@eos-aus.com ABOUT ELECTRO OPTIC SYSTEMS (ASX: EOS) EOS currently operates in two divisions DEFENCE SYSTEMS Defence Systems specialises in technology for weapon systems optimisation and integration, as well as ISR (Intelligence, Surveillance and Reconnaissance) and C4 systems for land warfare. Its key products include next-generation remote weapon systems, vehicle turrets, high-energy laser weapons (directed energy), as well as fully integrated and modular counter-UAS and C4 systems. SPACE SYSTEMS Space Systems specialises in applying EOS-developed optical sensors and effectors to detect, track and characterise objects in space. It includes capabilities in the domain of space control. FORWARD LOOKING STATEMENTS This announcement may contain certain "forward-looking statements" including statements regarding EOS' intent, belief or current expectations with respect to EOS' business and operations, market conditions, results of operations, financial condition, and risk management practices. The words "likely", "expect", "aim", "should", "could", "may", "anticipate", "predict", "believe", "plan" and other similar expressions are intended to identify forward-looking statements. Indications of, and guidance on, future earnings, financial position and performance, establishment costs and capital requirements are also forward-looking statements. Forward-looking statements including projections, guidance on future earnings and estimates are provided as a general guide only and should not be relied upon as an indication or guarantee of future performance. This announcement may contain such statements that are subject to risk factors associated with an investment in EOS. Forward- looking statements involve known and unknown risks, uncertainties and assumptions and other important factors that could cause the actual results, performances or achievements of EOS to be materially different from future results, performances or achievements expressed or implied by such statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this announcement